Clinical Trials on L-arginine in Germany
Total 2 results
-
NovartisCompletedEfficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease PatientsParkinson's Disease | L-dopa Induced DyskinesiaGermany
-
Aeglea BiotherapeuticsCompletedArginase I Deficiency | HyperargininemiaUnited States, Italy, Canada, France, United Kingdom, Austria, Germany